Cel­gene vet Jack­ie Fouse grabs the reins of a Vivek Ra­maswamy vant-up

Jack­ie Fouse has land­ed.

A lit­tle more than four months af­ter Fouse said she was “re­tir­ing” as pres­i­dent of Cel­gene, she’s back run­ning her own biotech as ex­ec­u­tive chair­man of Der­ma­vant, one of sev­er­al new “vants” that Roivant chief Vivek Ra­maswamy has kicked in­to play over the last three years.

Fouse wrapped up her fi­nal lap at Cel­gene a few days ago, end­ing a 3-month leg as a com­pa­ny ad­vis­er to see out her tran­si­tion from the big biotech, which has per­haps the busiest deal­mak­ing group in the in­dus­try.  She moves from a top job at a bell­wether com­pa­ny to a start­up with a few ad­vanced ther­a­pies in the clin­ic. And she tells me that the part­ner­ing work she did at Cel­gene will help her get start­ed on her new job as ex­ec­u­tive chair­man.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER